开放升主动脉及主动脉弓修复术后吻合口动脉瘤与假性动脉瘤的腔内弓部修复:病例系列
该回顾性病例系列纳入2018至2022年10例开放升主动脉和/或近端主动脉弓置换术后吻合口动脉瘤患者,采用定制双分支或三分支内分支弓部腔内移植物行b-TEVAR。技术成功9例(90%),择期患者全部存活,2例因包裹性破裂急诊手术者死亡,中位随访20个月。作者认为该技术可行,对不适合外科手术的患者是有前景的替代方案。
要点
- 定制双分支或三分支内分支弓部腔内移植物治疗开放术后吻合口动脉瘤技术成功9例(90%)。
- 8例择期患者全部存活,2例因包裹性破裂急诊手术者死亡。
- 术后30天内发生1例短暂性脑缺血发作,无早期移植物相关再干预。
核心结论
- 采用双分支或三分支内分支弓部腔内移植物行腔内弓部修复,治疗开放升主动脉和/或近端弓部置换术后吻合口动脉瘤技术可行,对不适合外科手术的患者是有前景的替代方案。
研究设计与样本
- 回顾性分析2018至2022年所有连续接受b-TEVAR的开放升主动脉和/或主动脉弓修复术后吻合口动脉瘤患者,共10例,均使用定制双分支或三分支内分支弓部腔内移植物。
- 研究终点为技术成功、30天及随访期死亡率/并发症和再干预。
主要发现
- 8例接受三分支、2例接受双分支弓部腔内移植物;8例择期手术,2例因包裹性破裂急诊手术。
- 技术成功9例(90%);择期患者全部存活,2例因包裹性破裂急诊手术者死亡。
- 术后30天内发生1例短暂性脑缺血发作,无早期移植物相关再干预。
- 中位随访20个月,1例出院后2个月因肺炎所致脓毒症死亡,未再观察到其他死亡或移植物相关再干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aim of the study was to investigate the outcomes of branched endovascular arch repair (b-TEVAR) with a custom-made double- or triple-branched arch endograft in patients with distal anastomotic aneurysms after open repair of the ascending aorta or proximal arch replacement. METHODS: Retrospective analysis was conducted of all consecutive patients with anastomotic aneurysms after open surgical repair involving the ascending aorta and/or aortic arch treated with b-TEVAR. All patients were treated with a custom-made double or triple inner-branched arch endograft. Study end points were technical success, 30-day and follow-up mortality/morbidity and re-interventions. RESULTS: Between 2018 and 2022, 10 patients were treated with custom-made double- or triple-branched thoracic endovascular aortic repair due to anastomotic aneurysms after open ascending aorta and/or proximal aortic arch replacement. Eight patients received a triple and 2 a double arch-branched endograft. Eight cases were performed electively and 2 urgently for contained rupture. Technical success was achieved in 9 cases (90%). All elective patients survived. Two patients treated due to contained ruptures expired. Within 30 postoperative days, 1 transient ischaemic attack occurred. No early endograft-related re-interventions were necessary. The median follow-up was 20 months. One patient died 2 months after discharge due to sepsis caused by pneumonia. No further deaths or endograft-related re-interventions were observed. CONCLUSIONS: Endovascular aortic arch repair with double or triple inner-branched arch endograft for anastomotic aneurysms after open ascending and/or proximal arch replacement is technically feasible and a promising alternative in a patient cohort unfit for surgery.
引用
- Becker D, Stana J, Prendes CF, et al. Endovascular arch repair of anastomotic aneurysm and pseudoaneurysm in patients after open repair of the ascending aorta and aortic arch: a case series. Eur J Cardiothorac Surg. 2023. PMID: 37889250. doi:10.1093/ejcts/ezad345
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。